Evaluation of artificial pancreas technology for continuous blood glucose monitoring in dogs

Journal of Artificial Organs

Volumn 14, Issue 2, 2011, Pages 133-139

  Mori, Akihiro ^a   Lee, Peter ^a   Yokoyama, Takeshi ^b   Oda, Hitomi ^a   Saeki, Kaori ^a   Miki, Yohei ^a   Nozawa, Satoshi ^a   Azakami, Daigo ^a   Momota, Yutaka ^a   Makino, Yuki ^a   Matsubara, Takako ^a   Osaka, Motohisa ^a   Ishioka, Katsumi ^a   Arai, Toshiro ^a   Sako, Toshinori ^a  

^a NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Artificial pancreas apparatus; Dog; Glucose

Indexed keywords

GLUCOSE; HEXOKINASE;

ACCURACY; ADULT; ANIMAL EXPERIMENT; ARTICLE; ARTIFICIAL PANCREAS; ARTIFICIAL PANCREAS TECHNOLOGY; BLOOD GLUCOSE MONITORING; CONTINUOUS BLOOD GLUCOSE MONITORING; CONTINUOUS PROCESS; CONTROLLED STUDY; DOG; FEMALE; GLUCOSE BLOOD LEVEL; GOLD STANDARD; HEXOKINASE METHOD; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; INTERMETHOD COMPARISON; MALE; NONHUMAN; PRIORITY JOURNAL; PROCESS OPTIMIZATION; REFERENCE VALUE; RELIABILITY; AMBULATORY MONITORING; ANIMAL; ANIMAL DISEASE; METHODOLOGY;

ADULT; ANIMALS; BLOOD GLUCOSE; DOGS; FEMALE; HUMANS; MALE; MONITORING, AMBULATORY; PANCREAS, ARTIFICIAL;

EID: 80055098584     PISSN: 14347229     EISSN: 16190904     Source Type: Journal    
DOI: 10.1007/s10047-011-0560-1     Document Type: Article

References (18)

1. Okabayashi T, Hanazaki K, Nishimori I, Sugimoto T, Maeda H, Yatabe T, Dabanaka K, Kobayashi M, Yamashita K. Continuous post-operative blood glucose monitoring and control using a closed-loop system in patients undergoing hepatic resection. Dig Dis Sci. 2008;53:1405-10. (Pubitemid 351514618)
2. Kono T, Hanazaki K, Yazawa K, Ashizawa S, Fisher WE, Wang X-P, Nose Y, Brunicaidi FC. Pancreatic polypeptide administration reduces insulin requirements of artificial pancreas in pancreatectomized dogs. Artif Organs. 2005;29:83-9.
3. Hiramatsu S, Sako Y, Mimura K, Iwashige K, Taniuchi S, Umeda F, Nawata H. Impaired feedback inhibition of insulin secretion by hyperinsulinemia in patients with insulinoma. Endocrine J. 1995;42:39-42.
4. Suehiro T, Osaki F, Ikeda Y, Arii K, Nakayama F, Ota K, Hashimoto K. Type 1 diabetes developed in a type 2 diabetic patient with severe insulin resistance. Diabetes Res Clin Pract. 2005;70:298-302. (Pubitemid 41539793)
5. Heinemann L, Linkeschova R, Rave K, Hompesch B, Sedlak M, Heise T. Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo. Diabetes Care. 2000;23:644-9. (Pubitemid 30321545)
6. Heise T, Nosek L, Ronn BB, Endahl L, Heinemann L, Kapitza C, Draeger E. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes. Diabetes. 2004;53:1614-20. (Pubitemid 38697678)
7. Madarame H, Kayanuma H, Shida T, Tsuchiya R. Retrospective study of canine insulinomas: eight cases (2005-2008). J Vet Med Sci. 2009;71:905-11.
8. Mori A, Lee P, Sako T, Mizutani H, Arai T. Successful intensive insulin treatment of type 1 diabetic dogs leads to restoration of peripheral leukocyte insulin signaling gene expression and enzyme activities. J Vet Med Sci. 2009;71:1017-26.
9. Sako T, Mori A, Lee P, Oda H, Saeki K, Miki Y, Kurishima M, Mimura K, Nozawa S, Mizutani H, Makino Y, Ishioka K, Arai T. Time-action profiles of insulin detemir in normal and diabetic dogs. Res Vet Sci. 2010 (in press). doi:10.1016/j.rvsc.2010.001.
10. Holford AL, Tobias KM, Bartges JW, Johnson BM. Adrenal response to adrenocorticotropic hormone in dogs before and after surgical attenuation of a single congenital portosystemic shunt. J Vet Intern Med. 2008;22:832-8. (Pubitemid 352039162)
11. Sakai M, Asano K, Nakata M, Takahashi T, Koie H, Yamaya Y, Watari T, Shibuya H, Sato T, Tokuriki M, Hasegawa A. Diabetes mellitus after resection of hepatocellular carcinoma with hypoglycemia in a dog. J Vet Med Sci. 2006;68:765-7. (Pubitemid 44198588)
12. Barman BN, Ashwood ER, Giddings JC. Separation and size distribution of red blood cells of diverse size, shape, and origin by flow/hyperlayer field-flow fractionation. Anal Biochem. 1993;212:35-42. (Pubitemid 23219449)
13. Hawkey CM, Dennett TB. Normal and abnormal red cells. In: A color atlas of comparative veterinary haematology. London: Wolfe Medical Publications Ltd; 1989. p. 9-57.
14. Higgins PJ, Garlick RL, Bunn HF. Glycosylated hemoglobin in human and animal red cells. Role of glucose permeability. Diabetes. 1982;31:743-8. (Pubitemid 12062861)
15. Rendell M, Stephen PM, Paulsen R, Valentine JL, Rasbold K, Hestorff T, Eastberg S, Shint DC. An interspecies comparison of normal levels of glycosylated hemoglobin and glycosylated albumin. Comp Biochem Physiol B. 1985;81:819-22.
16. Kadish AH, Hall DA. A new method for the continuous monitoring of blood glucose by measurement of dissolved oxygen. Clin Chem. 1965;11:869-75.
17. Yamashita K, Yatabe T. Intraoperative glycemic control procedures and the use of an artificial pancreas. World J Gastroenterol. 2009;15:4126-31.
18. Yamashita K, Okabayashi T, Yokoyama T, Yatabe T, Maeda H, Manabe M, Hanazaki K. Accuracy and reliability of continuous blood glucose monitor in post-surgical patients. Acta Anaesthesiol Scand. 2009;53:66-71.